The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prevalence of and predictive factors for sustained disease‐modifying antirheumatic drug–free remission in rheumatoid arthritis: Results from two large early arthritis cohorts
Abstract
Objective: Remission has become an attainable goal of rheumatoid arthritis (RA) treatment, especially since the advent of biologic antirheumatic therapy. Because little is known about patients who achieve disease remission with conventional treatment, we used 2 large independent inception cohorts to study the prevalence of and predictive factors for disease‐modifying antirheumatic drug (DMARD)–free sustained remission after treatment with conventional therapy. Methods: Remission of disease was assessed in 454 patients from the Leiden Early Arthritis Clinic (EAC) and in 895 patients from the British Early Rheumatoid Arthritis Study (ERAS) who fulfilled the American College of Rheumatology 1987 revised criteria for the classification of RA and were treated with conventional therapy. Sustained DMARD‐free remission was defined as fulfilling the following criteria for at least 1 year: 1) no current DMARD use, 2) no swollen joints, and 3) classification as DMARD‐free remission by the patient's rheumatologist. Predictive factors were identified by Cox regression analysis. Results: Sustained DMARD‐free remission was achieved by 68 of 454 patients (15.0%) in the Leiden EAC and by 84 of 895 patients (9.4%) in the ERAS. Six factors were associated with sustained DMARD‐free remission in both cohorts: acute onset, short symptom duration before inclusion, not smoking, little radiographic damage at baseline, absence of IgM rheumatoid factor (IgM‐RF), and absence of HLA shared epitope alleles. In the ERAS, low disease activity at baseline was also predictive of remission. Multivariate analyses revealed symptom duration and the absence of autoantibodies (anti–cyclic citrullinated peptide 2 and IgM‐RF) as independent predictors. Conclusion: Sustained DMARD‐free remission in RA patients treated with conventional therapy is not uncommon. Symptom duration at presentation and the absence of autoantibodies are associated with sustained DMARD‐free remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods.
Aickin, M., & Gensler, H. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.726 · Cited by 1,346
Cited by
Long‐term impact of delay in assessment of patients with early arthritis
van der Linden, M. P. M., le Cessie, S., Raza, K., van der Woude, D., Knevel, R., Huizinga, T. W. J., & van der Helm‐van Mil, A. H. M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27692 · Cited by 469
Self-citationTherapeutic advances in rheumatoid arthritis
Brown, P., Pratt, A. G., & Hyrich, K. L. (2024) · BMJ · doi:10.1136/bmj-2022-070856 · Cited by 312
Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?
de Rooy, D. P. C., van der Linden, M. P. M., Knevel, R., Huizinga, T. W. J., & van der Helm-van Mil, A. H. M. (2011) · Rheumatology · doi:10.1093/rheumatology/keq230 · Cited by 295
Self-citationSchett, G., Emery, P., Tanaka, Y., Burmester, G., Pisetsky, D. S., Naredo, E., Fautrel, B., & van Vollenhoven, R. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209201 · Cited by 294
Cappelli, L. C., Dorak, M. T., Bettinotti, M. P., Bingham, C. O., & Shah, A. A. (2019) · Rheumatology · doi:10.1093/rheumatology/key358 · Cited by 111
Metadata
- Authors
- van der Woude, D., Young, A., Jayakumar, K., Mertens, B. J., Toes, R. E. M., van der Heijde, D., Huizinga, T. W. J., & van der Helm‐van Mil, A. H. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-07-30
- Volume
- 60
- Issue
- 8
- Pages
- 2262-2271
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2063811338
- Cited by
- 224
- References
- 1
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of and predictive factors for sustained disease‐modifying antirheumatic drug–free remission in rheumatoid arthritis: Results from two large early arthritis cohorts. https://app.cochat.ai/papers/10.1002/art.24661
- The paper
- van der Woude, D., Young, A., Jayakumar, K., Mertens, B. J., Toes, R. E. M., van der Heijde, D., Huizinga, T. W. J., & van der Helm‐van Mil, A. H. M. (2009). Prevalence of and predictive factors for sustained disease‐modifying antirheumatic drug–free remission in rheumatoid arthritis: Results from two large early arthritis cohorts. Arthritis & Rheumatism. https://doi.org/10.1002/art.24661
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.